Insiders Genmab A/S Nasdaq

Stocks

GMAB

US3723032062

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 09:49:09 2026-09-10 EDT			5-day change	1st Jan Change
32.46 ^USD	-1.74%		-6.06%	+4.95%

09-08	Espiria Hållbar Framtid rose 4.5 percent in August, Vestas and Hansa Biopharma made positive contributions	FW
09-08	Barclays raises Genmab price target to 2,900 Danish kroner (2,500), reiterates overweight - BN	FW

Insiders

25-07-01	Genmab Announces Changes to Its Executive Committee	CI
25-07-01	Genmab's Chief Legal Officer Steps Down; Successor Named	MT
24-08-16	Genmab Names First Chief Technology, Chief Commercial Officers; COO to Exit	MT
24-08-16	Genmab A/S Announces Executive Changes	CI
24-03-13	Genmab A/S Announces Executive Changes	CI
23-03-28	Danish Biotechnology Group Genmab Names New Chief Strategy Officer	MT
23-03-28	Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	CI
22-03-29	Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	CI
22-03-01	Genmab Appoints New Chief Legal Officer, Chief People Officer	MT
22-03-01	Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	CI
21-02-22	Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	CI
20-03-26	Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	CI
20-03-26	Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	CI
20-03-10	Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	CI
20-02-21	Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	CI
19-10-30	Genmab A/S Announces Executive Changes	CI
19-03-11	Genmab A/S Announces Management Changes	CI
17-02-08	Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	CI
16-08-03	Genmab A/S Nominates Rolf Hoffmann to its Board of Directors	CI
15-03-26	Genmab A/S Announces Board Appointments	CI
13-04-17	Genmab A/S Elects Mats Pettersson to the Board of Directors	CI